Learn More
Description
The NaM160-1A3 monoclonal antibody specifically binds to the 116-kDa integrin β 1 chain (CD29). CD29 is expressed on the cell surface as a heterodimer with one of the distinct integrin α chains. With α 1 through α 6 (CD49a through CD49f), it forms the VLA-1 through VLA-6 complexes, respectively, and with α v (CD51), it forms α v β 1 integrin. As a result, CD29 has a broad tissue distribution, including leukocytes, endothelia, epithelia, and oocytes. Porcine CD29 is believed to be a major target for natural antibodies involved in rejection of pig-to-human xenografts, and a mAb to block recognition of pig CD29 may have therapeutic applications. NaM160-1A3 mAb does not crossreact with human peripheral blood lymphocytes or umbilical cord vein endothelial cells.
Specifications
Specifications
| Antigen | CD29 |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Clone | NaM160-1A3 |
| Concentration | 0.2mg/mL |
| Conjugate | Alexa Fluor 647 |
| Description | Integrin β1 chain |
| Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
| Host Species | Mouse |
| Immunogen | Pig platelets |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.